- $715.67m
- $701.64m
- $962.32m
- 99
- 93
- 51
- 95
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 713 | 590 | 607 | 833 | 962 |
Cost of Revenue | |||||
Gross Profit | 359 | 229 | 237 | 264 | 306 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 522 | 521 | 535 | 744 | 849 |
Operating Profit | 192 | 68.7 | 72.1 | 88.4 | 114 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 196 | 77.9 | 94.2 | 90.7 | 150 |
Provision for Income Taxes | |||||
Net Income After Taxes | 169 | 66.3 | 81 | 77.5 | 128 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 74.6 | 28.8 | 35.7 | 34 | 57.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 74.1 | 54.5 | 67.1 | 64 | 56.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.33 | 1.84 | 2.3 | 2.08 | 3.76 |
Dividends per Share | |||||
Special Dividends per Share |